Dear Lia,
Technically, no, but it may depend on the circumstances and the recent trial findings. I know of just two cases where women with primary BC have been offered herceptin or herceptin-based chemo and in both cases the women were stage III. However, as you are probably aware, just recently findings came out that show that herceptin prevents recurrences, so that may change things.
A friend who is a long-time AIDS survivor (and you don't become one of those without becoming an expert on the healthcare system) said that to have any chance of getting treatment that is not authorised under the NICE guidelines, you need to go to as senior a consultant as possible. You may need to sign "compassionate release" paperwork, basically waiving all rights if it goes wrong, which I think means that you couldn't sue them, but they are very hard to sue anyways. He said that money generally isn't the issue.
The main risk involved is that herceptin, when given after adriamycin can lead to heart problems. Unfortunately, the herceptin-based combos that don't have this risk, such as herceptin given with (taxotere or taxol) with or without carboplatin haven't yet gone through the trials proving their effectiveness. Epirubicin is also known to be gentler on the heart than adriamycin, but again there is the effectiveness issue involved.
My observation on UK consultants is that some of them will do things two seconds after the phase III results come out (my oncologist is like this fortunately), while others wait until the NICE guidelines change, which is usually years after the trial results are known. I doubt he would give me herceptin, though, because the data right now show that herceptin works for women who are less than six months out of chemo, although it can't hurt to ask.
Let me know how you get on.
Best wishes,
Christine
|